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Article Information  ABSTRACT: Medicinal plants are the most important source of life saving drugs for the 
majority of the Worlds’ population. The compounds which synthesized in the plant from the 
secondary metabolisms are called secondary metabolites; exhibit a wide array of biological and 
pharmacological properties. Stilbenes a small class of polyphenols, have recently gained the 
focus of a number of studies in medicine, chemistry as well as have emerged as promising 
molecules that potentially affect human health. Stilbenes are relatively simple compounds 
synthesized by plants and deriving from the phenyalanine/ polymalonate route, the last and key 
enzyme of this pathway being stilbene synthase. Here, we review the biological significance of 
stilbenes in plants together with their biosynthesis pathway, its chemistry and its 
pharmacological significances. 
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INTRODUCTION 
Plants are source of several drugs of natural origin and hence 
are termed as the medicinal plants. These drugs are various 
types of secondary metabolites produced by plants; several of 
them are very important drugs. Essentially, plant cell produced 
two types of metabolites: primary metabolites involved directly 
in growth and metabolism, viz., carbohydrates, lipid and 
protein, and secondary metabolites considered as the end 
product of primary metabolism and in general not involved in 
metabolic activity, viz., alkaloids, phenolics, essential oils, 
steroids, lignins, tannins etc. The plant biomasses cultivated in 
vitro are capable of biosynthesis of secondary metabolites 
typical for intact plants or they may serve as sources of entirely 
new molecules, not identified in nature. In effect, a path was 
opened for intensive biotechnological research into the 
potential use of in vitro cultures to produce highly valuable 
secondary metabolites, including compounds for which 
medical application could be found[1] . Polyphenolics are 
important constituents of grapes in determining the colour, 
taste and body of wines. Unlike other alcoholic beverages, red 
wine, which is obtained after maceration, contains phenolic 
compounds in high concentration up to 4 g/l, but relatively low 
quantities are present in white and rosé wines, i.e. about a tenth 
of those of red wines. Among these phenolic compounds, 
trans-resveratrol, belonging to the stilbene family, is a major 
active ingredient which can prevent or slow the progression of 
the major diseases, as well as extend the lifespans of various 
organisms from yeast to vertebrates [2,3]. Other natural stilbenes 
derived from resveratrol such as pterostilbene or piceatannol, 
display higher oral bioavailability and bioactivity than the 
parent compound, but are far less abundant in natural sources[4]. 
Some t-resveratrol analogues such as polyhydroxy and 
polymethoxy derivatives exhibit higher pharmacological 
activity than the parent compound [5]. 
 
Epidemiology 
Some epidemiologic studies in United States have examined 
the relationship between wine consumption and the risk of 
cancer. Contrary to other alcoholic beverages, the moderate 
wine consumption was associated with a decrease (or no 
increase) in the risk of oral and pharyngeal cancer [6] and breast 
cancer[7] using small cohorts in Italy found a minimum risk of 
cancer and cardiovascular disease associated with moderate 
alcohol consumption (wine being the main beverage). 
JOURNAL OF APPLIED PHARMACEUTICAL RESEARCH  
ISSN No. 2348 – 0335                                                                                 www.japtronline.com 
Roat et. al Stilbenes: chemistry and pharmacological properties 
 
 
Journal of Applied Pharmaceutical Research  October – December 2015  Volume 3 Issue 4  2 
Chemistry 
Stilbenes naturally occur in several plant families, such as the 
Cyperaceae, Dipterocarpaceae, Gnetaceae, and Vitaceae[8]. 
Grapes (Vitaceae) and products manufactured from grapes are 
viewed as the most important dietary sources of these 
substances[9] .They are a family of molecules belonging to the 
non-flavonoid polyphenol group. The essential structural 
skeleton comprises two aromatic rings joined by an ethylene 
bridge (C6-C2-C6).From this relatively simple structure, there is 
a large array of compounds: - monomers which varying in the 
number and position of hydroxyl groups, the substitution with 
sugars, methyl, methoxy and other residues and the steric 
configuration of the molecules (Fig. 1), - oligomers resulting 
from the different oxidative condensation of resveratrol 
monomer (dimers, trimers, tetramers,……). 
 
Figure 1: Structure of the main stilbene monomer derivatives 
from Vitis vinifera 
 
names R1 R2 R3 R4 
cis- and trans-resveratrol OH OH 0H H 
trans-pterostilbene OCH3 OCH3 OH H 
cis- and trans-piceid OGlc OH OH H 
cis- and trans-
resveratroloside 
OH OH OGlc H 
cis- and trans-resveratrol 
3,5-O-β-diglucoside 
OGlc OGlc OH H 
cis- and trans-resveratrol 
3,4’-O-β-diglucoside 
OGlc OH OGlc H 
trans-resveratrol 3,5,4’-
O-β-triglucoside 
OGlc OGlc OGlc H 
trans-piceatannol OH OH OH OH 
cis- and trans-astringin OGlc OH OH OH 
 
Monomers (Fig 1) 
Among stilbene monomers, resveratrol (3, 5, 4’-
trihydroxystilbene) has been identified as the major biological 
active compound, and most of the studies have focused on it.  
The two isomeric forms of resveratrol (cis- and trans-) have 
different chemical characteristics and biological activities. The 
trans-isomer is usually the more stable, and cis-trans-
interconversions can occur in the presence of heat or ultraviolet 
light.Other simple stilbenes have been isolated in Vitis 
vinifera : trans-pterostilbene and piceatannol. Besides the 
aglycone of resveratrol cited above, some resveratrol 
glucosides derivatives have been identified such as piceid and 
resveratroloside, two β-glucosides of resveratrol [10] together 
with astringin (piceatannol 3-O-β-glucoside). These 
compounds exist in their two isomeric forms, cis and trans 
(Waffo-Téguo et al., 1998). Furthermore, resveratrol di- and 
tri- glucoside derivatives have been recently isolated from Vitis 
vinifera [11.12]. 
 
Oligomers 
Besides monomers of stilbenes, some oligomers have been 
isolated from Vitis vinifera. They are eithers dimers, trimers 
and tetramers. These oligomers result from the different 
oxidative condensation of resveratrol monomer. 
 
Dimmers 
The dimers are divided into two major groups. One group (A) 
contains one five-membered oxygen heterocyclic ring bearing 
to aromatic ring (benzofuran ring) (Fig 2). Belonging this 
group, we have α-viniferin substituted or not with sugars[13] , α-
viniferin (also named resveratrol dehydrodimer) glucosylated 
or not[14] (Waffo et al., 2001) and α-viniferifuran[15] (Fig 2).The 
other group (group B) does not contain any oxygen 
heterocyclic ring. Among dimers belonging to this group, 
pallidol have been isolated in Vitis vinifera as well as its mono- 
and di-glucoside [14, 13] and parthenocissin A (Fig 3). 
2.2.4 – Trimers 
Recently, resveratrol trimer was detected in grapevine infected 
by downy mildew using HPLC coupled to Atmospheric 
Pressure Photoionisation (APPI) mass spectrometry. The 
structure was supposed to be α-viniferin [15] (Fig.4). 
2.2.5 – Tetramers 
Besides resveratrol dimers and trimer, stilbene tetramers were 
isolated from Vitis vinifera. They are divided into three groups: 
one group contains a bicyclo[6.3.0]undecane ring system. Into 
this group we have viniferol A (Fig. 5). Second group has a 
bicyclo[5.3.0]decane ring system. Resveratrol tetramers 
belonging to this group are: viniferal B and C, vaticanol B, and 
vaticaphenol A (Fig.5) third group contains benzofuran system 
usually trans-2-aryl-2,3-benzofuran moiety (Fig 6). Tetramers 
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belonging this group are: vitisifuran A and B and iso- and 
hopeaphenol (two cyclic symmetric tetramers) [14] (Ito et al., 
1997). 
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Figure 2: Structure of the main stilbene dimer derivatives 
(group A) from Vitis vinifera 
 
 
Figure 3: Structure of the main stilbene dimer derivatives 
(group B) from Vitis vinifera 
 
Figure 4: Structure of the stilbene trimer from Vitis vinifera 
 
Figure 5: Structure of the stilbene tetramer from Vitis vinifera 
 
Figure 6: Structure of the stilbene tetramer from Vitis vinifera 
 
 
Figure 7: General biosynthesis pathway of stilbenes and 
flavonoids 
 
Biosynthesis of stilbenes 
The immediate precursors of resveratrol are p-coumaroyl CoA 
and malonyl CoA in a molar ratio of 1 to 3. The latter is 
derived from elongation of acetyl CoA units and the former 
from phenylalanine, which can be synthesized from sugars via 
the shikimate pathway. Following oxidative deamination 
catalysed by Phenylalanine Ammonia Lyase (PAL), 
phenylalanine is converted to cinnamic acid which in turn is 
enzymatically hydroxylated to p-coumaric acid. In the final 
step, p-coumaroyl CoA is generated from the free coenzyme by 
a specific CoA ligase. The condensation of p-coumaroyl CoA 
with 3 molecules of malonyl CoA is accomplished through the 
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activity of the stilbene synthase (STS), which leads to trans- 
resveratrol (Fig. 7). However, the exact biosynthetic formation 
of these derivatives is unknown. 
 
In Vitis vinifera varieties, a number of different 
hydroxystilbenes are present in several parts of the grape plant 
as constitutive compounds of the lignified organs (roots, canes, 
seeds, stems, ripe cluster stems), and as induced substances (in 
leaves and berries) probably acting as phytoalexins in the 
mechanisms of grape resistance against pathogens. Both 
resveratrol and piceid can be found in grape products, with the 
concentration of the glucoside usually being significantly 
higher than the aglycone .In grape berries, stilbene synthesis is 
primarily located at the skin cells and it is absent or low in the 
fruit flesh. The greater part of the resveratrol in the skins is in 
both glycosidic forms (pieced isomers), whereas pterostilbene 
is detected in very low levels in healthy and immature grape 
berries [17] found that piceids were the major components of 
grape juices, averaging a total of 4 mg/L in red grape juices and 
0.5 mg/L in white ones. In seeds, only trans- and cis- 
resveratrol was detected. In grape cell suspension cultures, 
several stilbenes have been isolated: Resveratrol, piceid, 
resveratroloside and astringin, all in the two isomeric forms cis- 
and trans (Fig.1) Recently, three new resveratrol diglucosides, 
cis- and trans-resveratrol 3,5-O-β-diglucoside [12] and trans-
resveratrol 3,4’-O-β-diglucoside [18] (Fig.1) have been isolated 
together with a new resveratrol triglucoside, trans-resveratrol 
3,5,4’-O-β-triglucoside [12] . (Fig.1).Furthermore, resveratrol 
dimers have been identified, among them, trans-α-viniferin 
together with trans-α-viniferin 11- and 11'-O-ß-glucoside and 
pallidol [14]. Besides the monomers of stilbenes, some 
resveratrol dimers have been characterized from the wines: - 
from German commercial white wines (Riesling), α-viniferin 
diglucosides and pallidol mono- and di-glucosides have been 
identified at very low levels (< 0.05 mg/L) [13] from French 
commercial red wines low levels (from 0.5 to 4.8 mg/L) of 
trans-α-viniferin, parthenocissin A, and pallidol have been 
isolated [19]; and - from commercial Brazilian red wines, trans-
α-viniferin have been found only in the youngest vintage 
(2002) with an average level of 11.7mg/L [20] . 
 
BIOLOGICAL & PHARMACOLOGICAL ACTIVITIES 
Bioavailability and metabolism 
Stilbenes are naturally occurring polyphenolic compounds 
which have been reported to have potential preventive activities 
in human diseases. Among these stilbenes, trans-resveratrol, 
which is mainly found in peanuts, grapes and red wine, is one 
of the most important in terms of biological activities, since it 
has been reported to exert anticarcinogenic, antioxidant and 
cardioprotective activities [2]. 
 
The absorption of resveratrol using an isolated preparation of 
luminally and vascularly perfused rat small intestine[21]. 
Pharmacokinetics of trans-resveratrol following oral 
administration to rat (50 mg/kg)[22]. They determined 
resveratrol and glucuronide metabolites concentrations in 
plasma samples. They showed that resveratrol is bioavailable at 
38% when administrated in a solution of hydroxypropyl ß-
cyclodextrin and its systemic exposure was approximately 46-
fold lower that of these glucuronides. Administration of 20 
mg/kg mouse, resveratrol glucuronide, but also resveratrol 
sulfate as the resveratrol metabolites in the serum samples. 
However, only traces of unconjugated resveratrol were 
observed[23] 
 
Cardiovascular protection 
Antioxidant activity. Free radicals derived from molecular 
oxygen, such as superoxide, hydroxyl, hydroperoxyl radicals 
and nitric oxide, are constantly generated in vivo for specific 
metabolic purposes [24] . Free radical concentrations are 
increased either by their overproduction or by a deficiency in 
antioxidant defense systems. The reactivity of radicals can 
cause severe damage to biological molecules, especially to 
DNA, lipids and proteins [24] This damage probably contributes 
to the development of major chronic diseases including cancer, 
Parkinson’s disease, senile dementia and atherosclerosis. 
Resveratrol can also prevent the initial events of atherosclerosis 
in endothelial cells - by inhibition of the enzymatic systems 
producing reactive oxygen species such as NADPH oxidase 
and hypoxanthine/xanthine oxidase, - and by inhibition both 
the expression of adhesion molecules and the monocyte 
adhesion to endothelial cells[25]. Resveratrol is able to regulate 
vasomotion which is impaired in atherosclerosis. The key 
regulators of the vasomotor function are the vasodilatator NO 
and the vasoconstrictor endothelin-1 [25]. Taken together, these 
biological activities in vitro of polyphenols such as trans-
resveratrol, (antioxidant, anti-atherogenic, anti-thrombotic, 
vasorelaxant and anti-hypertensive) could explain the 
beneficial effects of wine in the prevention of cardiovascular 
disease. Biological activities after polyphenols or wine 
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ingestion. Some in vivo studies have been carried out in 
animals and human volunteers in order to show these protective 
effects after wine or pure compound consumption found that 
red wine notably reduced coronary atherosclerosis in rabbit. 
Using a hamster model of atherosclerosis [26], showed aortic 
fatty streak area was significantly reduced (76%) in the group 
receiving resveratrol at a level mimicking a moderate 
consumption of red wine. Intravenous and intragastric 
administration of red wine, grape juice and not white wine 
inhibited in vivo platelet activity and thrombosis in canine 
coronary arteries [27] . 
 
Cancer Chemoprevention 
The term « chemoprevention » can be defined as the ingestion 
of non-toxic quantities of chemical agents (dietary or 
pharmaceutical) that are able of preventing, inhibiting or 
reversing the process of carcinogenesis [28] Chemopreventive 
agents can act by various mechanisms on this process [29] 
(Alberts et al., 1999): (1) anti-initiating activities (inhibition of 
carcinogen formation in the body and of uptake ; inhibition of 
the metabolic activation of carcinogens by Phase I enzymes  
such as cytochrome P450 enzymes, or increase in their 
detoxification by Phase II enzymes such as transferases leading 
to an easier excretion ; scavenging of free radicals and trapping 
ultimate carcinogens preventing their interactions with DNA). 
These compounds are referred to as « blocking agents » due to 
their ability to prevent initiation. In addition, several reports 
indicate that trans-resveratrol inhibits the proliferation of a 
wide variety of tumor cells [30] . The cancer chemopreventive 
activity of trans-resveratrol was established in various assays 
reflecting the three major stages of carcinogenesis [31].  
 
Neurodegenerative diseases 
Resveratrol promotes antiaging effects in numerous organisms. 
It modulates pathomechanisms of debilitating neurological 
disorders, such as ischemia, Huntington’s disease (HD), PD, 
and AD [32]. In rat hippocampal neurons, resveratrol inhibits 
voltage-activated potassium currents, suggesting that may be 
useful for treating ischemia brain injury [33] .  
 
In midbrain dopaminergic neurons, resveratrol protects neuron 
cultures against several type of insults related to PD 
pathogenesis like cytotoxic effects induced by 1-methyl-4-
phenyl pyrimidium, sodium azide, thrombin and DNA damage. 
In Huntington’s disease, resveratrol rescued mutant 
polyglutamine-specific cell death in neuronal cells derived 
from HdhQ111 knock-in mice and from transgenic C. elegans 
both models for HD [34]. In gerbil ischemia model, 
administration of resveratrol during the early stage of cerebral 
ischemia could protect against neuronal death in hippocampal 
CA1 area and concomitantly inhibit glial cell activation [35]. 
 
CONCLUSION 
Stilbenes and its derivatives were found to be potent 
antioxidant, anticancer, antihyperlipidemic, antidiabetic, and 
anti-inflammatory. This would offer remarkable potential for 
the exploitation stilbenes used in nutraceuticals, and 
pharmaceutical industries.However, further series of studies are 
required to prove its clinical reliability, safety, and efficacy. 
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